# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-019382
Filing Date
2024-04-11
Accepted
2024-04-11 16:41:09
Documents
5
Period of Report
2024-06-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | ny20024160x1_pre14a.htm | PRE 14A | 700963
2 |  | logo_appliedtherapeutics.jpg | GRAPHIC | 31301
3 |  | sig_shoshanashendelman.jpg | GRAPHIC | 16900
4 |  | ny20024160x1-pc_1.jpg | GRAPHIC | 582990
5 |  | ny20024160x1-pc_2.jpg | GRAPHIC | 553111
| Complete submission text file | 0001140361-24-019382.txt |  | 2332314

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38898 | Film No.: 24838999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)